Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1951 4
1952 4
1953 4
1954 4
1955 2
1956 3
1957 5
1958 2
1959 2
1960 2
1961 4
1962 2
1963 3
1965 4
1966 1
1967 1
1968 2
1969 3
1970 3
1971 6
1972 5
1973 7
1974 15
1975 16
1976 16
1977 10
1978 13
1979 6
1980 11
1981 10
1982 12
1983 7
1984 14
1985 8
1986 14
1987 8
1988 19
1989 8
1990 14
1991 9
1992 7
1993 4
1994 5
1995 12
1996 11
1997 10
1998 8
1999 9
2000 6
2001 7
2002 7
2003 8
2004 9
2005 13
2006 22
2007 21
2008 29
2009 28
2010 25
2011 39
2012 35
2013 37
2014 59
2015 48
2016 56
2017 70
2018 52
2019 65
2020 99
2021 79
Text availability
Article attribute
Article type
Publication date

Search Results

1,058 results
Results by year
Filters applied: . Clear all
Page 1
177Lu-PSMA Radioligand Therapy for Prostate Cancer.
Fendler WP, Rahbar K, Herrmann K, Kratochwil C, Eiber M. Fendler WP, et al. Among authors: herrmann k. J Nucl Med. 2017 Aug;58(8):1196-1200. doi: 10.2967/jnumed.117.191023. Epub 2017 Jun 29. J Nucl Med. 2017. PMID: 28663195 Free article. Review.
Radiotheranostics: a roadmap for future development.
Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, Gambhir SS, Hricak H, Weissleder R. Herrmann K, et al. Lancet Oncol. 2020 Mar;21(3):e146-e156. doi: 10.1016/S1470-2045(19)30821-6. Lancet Oncol. 2020. PMID: 32135118 Free PMC article. Review.
Driving the Future of Nuclear Medicine.
Herrmann K, Veit-Haibach P, Weber WA. Herrmann K, et al. J Nucl Med. 2019 Sep;60(Suppl 2):1S-2S. doi: 10.2967/jnumed.119.232264. J Nucl Med. 2019. PMID: 31481584 Free article. No abstract available.
Diagnosis and Screening of Patients with Fabry Disease.
Vardarli I, Rischpler C, Herrmann K, Weidemann F. Vardarli I, et al. Among authors: herrmann k. Ther Clin Risk Manag. 2020 Jun 22;16:551-558. doi: 10.2147/TCRM.S247814. eCollection 2020. Ther Clin Risk Manag. 2020. PMID: 32606714 Free PMC article. Review.
PSMA Ligands for PET Imaging of Prostate Cancer.
Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Afshar-Oromieh A, Herrmann K, Eiber M. Schwarzenboeck SM, et al. Among authors: herrmann k. J Nucl Med. 2017 Oct;58(10):1545-1552. doi: 10.2967/jnumed.117.191031. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687599 Free article. Review.
The Future of Nuclear Medicine, Molecular Imaging, and Theranostics.
Weber WA, Czernin J, Anderson CJ, Badawi RD, Barthel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM, Grimm J, Herrmann K, Kostakoglu L, Lewis JS, Mankoff DA, Peterson TE, Schelbert H, Schöder H, Siegel BA, Strauss HW. Weber WA, et al. Among authors: herrmann k. J Nucl Med. 2020 Dec;61(Suppl 2):263S-272S. doi: 10.2967/jnumed.120.254532. J Nucl Med. 2020. PMID: 33293447 Free article. Review. No abstract available.
CXCR4 Ligands: The Next Big Hit?
Walenkamp AME, Lapa C, Herrmann K, Wester HJ. Walenkamp AME, et al. Among authors: herrmann k. J Nucl Med. 2017 Sep;58(Suppl 2):77S-82S. doi: 10.2967/jnumed.116.186874. J Nucl Med. 2017. PMID: 28864616 Free article. Review.
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.
Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K; Vorstand der Interdisziplinären AG für Hybride Bildgebung in alphabetischer Reihenfolge:; Vorstand der Deutschen Röntgengesellschaft (DRG) und der Deutschen Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge:. Umutlu L, et al. Among authors: herrmann k. Rofo. 2019 Apr;191(4):289-297. doi: 10.1055/a-0828-8654. Epub 2019 Feb 28. Rofo. 2019. PMID: 30818411 Free article. English.
Consensus on molecular imaging and theranostics in prostate cancer.
Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O'Sullivan JM, Padhani AR, Schalken JA, Scher HI, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG. Fanti S, et al. Among authors: herrmann k. Lancet Oncol. 2018 Dec;19(12):e696-e708. doi: 10.1016/S1470-2045(18)30604-1. Lancet Oncol. 2018. PMID: 30507436
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.
Eiber M, Fendler WP, Rowe SP, Calais J, Hofman MS, Maurer T, Schwarzenboeck SM, Kratowchil C, Herrmann K, Giesel FL. Eiber M, et al. Among authors: herrmann k. J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S. doi: 10.2967/jnumed.116.186767. J Nucl Med. 2017. PMID: 28864615 Free article. Review.
1,058 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page